{
    "2021-02-05": [
        [
            {
                "time": "",
                "original_text": "基因测序行业一周风云榜：美年健康成功“卖子”拉动业绩，华大基因定增20亿元",
                "features": {
                    "keywords": [
                        "基因测序",
                        "美年健康",
                        "卖子",
                        "华大基因",
                        "定增"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“牛熊市”继续，低估值银行地产成新风口？",
                "features": {
                    "keywords": [
                        "牛熊市",
                        "低估值",
                        "银行",
                        "地产",
                        "风口"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "房地产"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "惠誉：降美年健康(002044.SZ)长期发行人评级和高级无抵押评级至“B+”，展望“稳定”",
                "features": {
                    "keywords": [
                        "惠誉",
                        "美年健康",
                        "评级下调",
                        "B+",
                        "稳定"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "惠誉：下调美年健康IDR评级至“B+”，展望“稳定” 主体评级下调",
                "features": {
                    "keywords": [
                        "惠誉",
                        "美年健康",
                        "IDR评级",
                        "B+",
                        "主体评级下调"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "325公司利润环比连增80家步入绩优股行列",
                "features": {
                    "keywords": [
                        "公司利润",
                        "环比增长",
                        "绩优股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}